Raleigh Capital Management Inc. Acquires 771 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Raleigh Capital Management Inc. grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 66.0% during the third quarter, Holdings Channel reports. The firm owned 1,940 shares of the healthcare conglomerate’s stock after purchasing an additional 771 shares during the period. Raleigh Capital Management Inc.’s holdings in UnitedHealth Group were worth $1,134,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $27,000. Macroview Investment Management LLC raised its stake in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. Delos Wealth Advisors LLC boosted its stake in UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the period. Bbjs Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at about $31,000. Finally, Global Wealth Strategies & Associates boosted its position in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 0.3 %

Shares of NYSE UNH opened at $571.46 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The firm has a 50-day moving average of $584.55 and a 200 day moving average of $535.49. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The stock has a market cap of $527.70 billion, a P/E ratio of 37.23, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the previous year, the business posted $6.56 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent analyst reports. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Cantor Fitzgerald boosted their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Barclays boosted their target price on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, Stephens lowered their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.